For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic ...
The Punch on MSN4h
Gene therapy delivers alternative sickle cell cure in USSebastien Beauzile from Laurelton, Long Island, has become the first person in New York State to be cured of sickle cell ...
Jeniffer Adhiambo Ayara, a 27-year-old mother from Ahero, Kisumu County, is a woman caught in the relentless storm of ...
Pulse Nigeria on MSN5h
Sickle Cell Cure: See the country where treatment is freeHowever, the cost of this treatment remains a major barrier for many in Nigeria. A bone marrow transplant costs approximately ...
In a world where differences often lead to discrimination, Temitayo Adekola's novelette Trauma brings to light the silent ...
Those who already own VRTX stock may retain it for some time to see if its CF sales continue to rise and how the Journavx and ...
For the 25th anniversary of 'Final Destination,' James Wong, Glen Morgan, Kerr Smith and more look back at the enduring ...
Dr Anup Rawool, Consultant in Clinical and Cancer Genetics at Sahyadri Hospitals, Pune, discusses innovative therapies and ...
From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 ...
WITH the Premier Volleyball League All-Filipino Conference quarterfinals proving to be a battleground where no team is safe, ...
The competition between U.S. and Chinese biotech companies is particularly fierce in one field: CRISPR gene editing. Here are ...
Are you reluctant to invest in stocks right now? That's understandable. Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility. However, three Fool.com ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback